Yanchun Qu

447 total citations
35 papers, 332 citations indexed

About

Yanchun Qu is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Yanchun Qu has authored 35 papers receiving a total of 332 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 10 papers in Pulmonary and Respiratory Medicine and 9 papers in Cancer Research. Recurrent topics in Yanchun Qu's work include Lung Cancer Treatments and Mutations (6 papers), Cancer-related molecular mechanisms research (5 papers) and Cancer Genomics and Diagnostics (4 papers). Yanchun Qu is often cited by papers focused on Lung Cancer Treatments and Mutations (6 papers), Cancer-related molecular mechanisms research (5 papers) and Cancer Genomics and Diagnostics (4 papers). Yanchun Qu collaborates with scholars based in China, United States and Australia. Yanchun Qu's co-authors include Jianping Bai, Yi‐Hong Liu, Haibo Zhang, Ze Yang, Lirong Liu, Yan-juan Zhu, Haibo Zhang, Liang Sun, Jun Zhang and Yong Li and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and Frontiers in Immunology.

In The Last Decade

Yanchun Qu

32 papers receiving 327 citations

Peers

Countries citing papers authored by Yanchun Qu

Since Specialization

Citations

This map shows the geographic impact of Yanchun Qu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanchun Qu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanchun Qu more than expected).

Fields of papers citing papers by Yanchun Qu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanchun Qu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanchun Qu. The network helps show where Yanchun Qu may publish in the future.

Co-authorship network of co-authors of Yanchun Qu

This figure shows the co-authorship network connecting the top 25 collaborators of Yanchun Qu. A scholar is included among the top collaborators of Yanchun Qu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanchun Qu. Yanchun Qu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Efficacy and safety of tislelizumab plus anlotinib and irinotecan as second-line treatment for extensive-stage small cell lung cancer: a single-arm, open-label, phase II trial 2025 ·EClinicalMedicine ·Xian Chen, Jiao Wang, Lirong Liu, (unknown), Wenzhu Li, Rui Zhou, (unknown), Yanchun Qu, Yong Li, Yanjuan Zhu, (unknown), Haibo Zhang	0
2	Durable response to Olaparib in EGFR and somatic BRCA2-mutated lung adenocarcinoma with leptomeningeal metastases: a case report 2025 ·Frontiers in Oncology ·(unknown), Lirong Liu, Wenjie Zhao, Yanchun Qu, Rui Zhou, Tianlin Wang, (unknown), (unknown), Haibo Zhang	0
3	Computational Biomimetics of Winged Seeds 2024 ·ACM Transactions on Graphics ·(unknown), (unknown), Yanchun Qu, Bo Zhu, Tao Du	0
4	Case report: A case of duodenal adenocarcinoma achieving significantly long survival treating with immune checkpoint inhibitors and chemotherapy without positive biomarkers 2022 ·Frontiers in Immunology ·Xian Chen, Rui Zhou, (unknown), (unknown), Yanchun Qu, Wenzhu Li, (unknown), Lirong Liu, (unknown), Haibo Zhang	2
5	Case Report: Two Cases of Soft-Tissue Sarcomas: High TMB as a Potential Predictive Biomarker for Anlotinib Combined With Toripalimab Therapy 2022 ·Frontiers in Immunology ·Yong Li, Yi‐Hong Liu, Yanchun Qu, Xian Chen, (unknown), (unknown), (unknown), Ying Cheng, (unknown), Haibo Zhang	3
6	Partial Response to Pyrotinib Plus Capecitabine in an Advanced Breast Cancer Patient with HER2 Amplification and R157W Mutation After Anti-HER2 Treatment: A Case Report and Literature Review 2021 ·OncoTargets and Therapy ·Yanchun Qu, (unknown), (unknown), Yong Li, (unknown), Haibo Zhang	2
7	Acupuncture for cancer pain: protocol for a pilot pragmatic randomised controlled trial 2019 ·BMJ Open ·Yihan He, Brian H. May, Anthony Lin Zhang, Xinfeng Guo, Yi‐Hong Liu, Yanchun Qu, (unknown), Chuanjian Lu, Charlie Changli Xue, Haibo Zhang	6
8	Alternatively spliced isoforms reveal a novel type of PTB domain in CCM2 protein 2019 ·Scientific Reports ·Xiaoting Jiang, (unknown), Yanchun Qu, (unknown), (unknown), Ahmed Badr, Jun Zhang	21
9	Meta-analysis of the role of bevacizumab in extensive stage small cell lung cancer 2017 ·Oncology Letters ·Yan-juan Zhu, Haibo Zhang, Yi‐Hong Liu, Jianping Bai, Yong Li, Lirong Liu, Yanchun Qu, (unknown), Xian Chen	7
10	Analysis of immune status after iodine-125 permanent brachytherapy in prostate cancer 2017 ·OncoTargets and Therapy ·E Du, Lin Wang, Changying Li, Changwen Zhang, Yanchun Qu, (unknown), (unknown), Kuo Yang, Zhihong Zhang	11
11	Quantitative cell-free circulating EGFR mutation concentration is correlated with tumor burden in advanced NSCLC patients 2017 ·Lung Cancer ·Yan-juan Zhu, Haibo Zhang, Yi‐Hong Liu, Fuli Zhang, Yazhen Zhu, Yong Li, Jianping Bai, Lirong Liu, Yanchun Qu, (unknown), Xian Chen, Yan Li, Guangjuan Zheng	28
12	Association of mutant EGFR L858R and exon 19 concentration in circulating cell-free DNA using droplet digital PCR with response to EGFR-TKIs in NSCLC 2017 ·Oncology Letters ·Yan-juan Zhu, Haibo Zhang, (unknown), Yazhen Zhu, Jun Chen, Yong Li, Jianping Bai, Lirong Liu, Yanchun Qu, (unknown), Xian Chen, Guangjuan Zheng	19
13	Yin-Cold or Yang-Heat Syndrome Type of Traditional Chinese Medicine Was Associated with the Epidermal Growth Factor Receptor Gene Status in Non‐Small Cell Lung Cancer Patients: Confirmation of a TCM Concept 2017 ·Evidence-based Complementary and Alternative Medicine ·Yan-juan Zhu, Haibo Zhang, Lirong Liu, Yi‐Hong Liu, Fuli Zhang, Jianping Bai, Yong Li, Yanchun Qu, (unknown), Xian Chen, Yan Li, (unknown), Aihua Ou	25
14	Association of genetic variations in miR-146a rs2910164 and miR-149 rs11614913 with the development of classic Kaposi sarcoma 2016 ·Genetics and Molecular Research ·Hsin‐Yi Yang, Qi Long Lu, Xuemei Wu, (unknown), Yanchun Qu, (unknown), Xingxiang Pu	4
15	Haptoglobin 2-2 Genotype Is Associated with Increased Risk of Type 2 Diabetes Mellitus in Northern Chinese 2012 ·Genetic Testing and Molecular Biomarkers ·Xiaohong Shi, Liang Sun, Li Wang, (unknown), Junfeng Sun, Xiaoquan Zhu, Lei Tang, Yanchun Qu, Ze Yang	20
16	Changes in the Expression of Bone Morphogenetic Protein 7 and Tamm– Horsfall Protein in the Early Stages of Diabetic Nephropathy 2012 ·Nephro-Urology Monthly ·Yanchun Qu, E Du, Yue Zhang, Shengzhi Li, Ruifa Han, Mengsheng Qiu	5
17	Variation in the PTEN-induced putative kinase 1 gene associated with the increase risk of type 2 diabetes in northern Chinese 2011 ·Journal of Genetics ·Yanchun Qu, Liang Sun, Ze Yang, Ruifa Han	12
18	The haplotype identified in LEPR gene is associated with type 2 diabetes mellitus in Northern Chinese 2008 ·Diabetes Research and Clinical Practice ·Yanchun Qu, Ze Yang, Feng Jin, Liang Sun, Jie Feng, Lei Tang, (unknown), Xiaoquan Zhu, Xiaohong Shi, Hong Sun, Binyou Wang, Li Wang	6
19	The Ser311Cys variation in the paraoxonase 2 gene increases the risk of type 2 diabetes in northern Chinese 2008 ·Journal of Genetics ·Yanchun Qu, Ze Yang, Feng Jin, Liang Sun, (unknown), Linong Ji, Hong Sun, Binyou Wang, Li Wang	3
20	Analysis of the relationship between three coding polymorphisms in LEPR gene and obesity in northern Chinese 2007 ·Obesity Research & Clinical Practice ·Yanchun Qu, Ze Yang, Feng Jin, Liang Sun, (unknown), Hong Sun, Binyou Wang, Li Wang	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact